Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity

被引：74

作者：

Cavaletti, G

Zanna, C

机构：

[1] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Monza, Italy

[2] Sigma Tau Pharmaceut Co, Pomezia, Italy

来源：

EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷 / 14期

关键词：

D O I：

10.1016/S0959-8049(02)00229-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1832 / 1837

页数：6

共 53 条

[1] Evidence that nerve growth factor promotes the recovery of peripheral neuropathy induced in mice by Cisplatin: behavioral, structural and biochemical analysis [J].

Aloe, L ;

Manni, L ;

Properzi, F ;

De Santis, S ;

Fiore, M .

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2000, 86 (1-2) :84-93

[2] NERVE GROWTH-FACTOR PREVENTS TOXIC NEUROPATHY IN MICE [J].

APFEL, SC ;

LIPTON, RB ;

AREZZO, JC ;

KESSLER, JA .

ANNALS OF NEUROLOGY, 1991, 29 (01) :87-90

[3]

APFEL SC, 1993, ANN NY ACAD SCI, V692, P243

[4] NERVE GROWTH-FACTOR PREVENTS EXPERIMENTAL CISPLATIN NEUROPATHY [J].

APFEL, SC ;

AREZZO, JC ;

LIPSON, L ;

KESSLER, JA .

ANNALS OF NEUROLOGY, 1992, 31 (01) :76-80

[5] Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy [J].

Apfel, SC ;

Kessler, JA ;

Adornato, BT ;

Litchy, WJ ;

Sanders, C ;

Rask, CA .

NEUROLOGY, 1998, 51 (03) :695-702

[6] CARNITINE [J].

BIEBER, LL .

ANNUAL REVIEW OF BIOCHEMISTRY, 1988, 57 :261-283

[7]

Bove L, 2001, J EXP CLIN CANC RES, V20, P277

[8]

Boyle FM, 1996, J PHARMACOL EXP THER, V279, P410

[9] The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin [J].

Boyle, FM ;

Beatson, C ;

Monk, R ;

Grant, SL ;

Kurek, JB .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (06) :429-434

[10]

Campana WM, 1998, NEUROTOXICOLOGY, V19, P237

← 1 2 3 4 5 6 →